UFF
IART icon

USA Financial Formulas’s Integra LifeSciences IART Stock Holding History

USA Financial Formulas’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-7
Closed – – 219
2018
Q4 		$0 Buy
+7
New +$384 ﹤0.01% 366
2016
Q4 		– Sell
-12,646
Closed -$522K – 295
2016
Q3 		$522K Buy
+12,646
New +$530K 0.13% 131
2015
Q4 		– Sell
-13,932
Closed -$415K – 107
2015
Q3 		$415K Sell
13,932
-2,410
-15% -$75.4K 0.27% 58
2015
Q2 		$450K Sell
16,342
-14,892
-48% -$397K 0.14% 134
2015
Q1 		$787K Buy
+31,234
New +$738K 0.26% 84

Other funds holding IART

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

USA Financial Formulas's IART Position: Q1 2019 in Review

USA Financial Formulas sold out of Integra LifeSciences (IART) in Q1 2019, closing a stake of 7 shares.

USA Financial Formulas first reported a position in IART in Q1 2015 and held it in 5 quarters. The position peaked at $787K in Q1 2015. 259 funds tracked by Wall St. Rank hold IART as of Q1 2019.

  • USA Financial Formulas reported no remaining Integra LifeSciences position as of Q1 2019 after selling out during the quarter.
  • USA Financial Formulas sold 7 Integra LifeSciences shares in Q1 2019.
  • USA Financial Formulas first reported a position in Integra LifeSciences in Q1 2015 and held it in 5 quarters.
  • USA Financial Formulas's Integra LifeSciences position peaked at $787K in Q1 2015.
  • 259 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2019.

Based on USA Financial Formulas's 13F filing for Q1 2019, filed 14 May 2019.